Anti-Xa Activity-Guided Edoxaban Therapy for Cancer-Associated Venous Thromboembolism?

Am J Ther. 2022 Nov-Dec;29(6):e754-e757. doi: 10.1097/MJT.0000000000001202. Epub 2020 May 25.

Affiliations

¹ Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.
² Department of Hematology and Blood Transfusion, National Centre of Hemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.

PMID: 32496437
DOI: 10.1097/MJT.0000000000001202

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use
Factor Xa Inhibitors / therapeutic use
Humans
Neoplasms* / complications
Pyridines / therapeutic use
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / etiology

Substances

edoxaban
Anticoagulants
Pyridines
Factor Xa Inhibitors